Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants

Overview of attention for article published in JAMA: Journal of the American Medical Association, September 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 6 news outlets
blogs: 4 blogs
twitter: 43 X users

facebook: 1 Facebook page
guideline: 1 clinical guideline source
podcasts: 1 podcast

Readers on

mendeley: 62 Mendeley

So far, Altmetric has seen 6 news stories from 6 outlets.

International pioneering neonatal study

Hippocratic Post, 24 Nov 2023

A pioneering neonatal study has reported its two-year findings, confirming that a novel approach developed in Australia can…

Survival Unaffected by Surfactants in Preterm Infants With Respiratory Distress

Rheumatology Advisor, 15 Sep 2023

Minimally invasive surfactant therapy (MIST) did not reduce mortality or neurodevelopmental disability (NDD) risk in children 2…

El surfactante muestra algunos beneficios en los primeros 2 años de los bebés

Espanol.news, 14 Sep 2023

La terapia con surfactante mínimamente invasivo (MIST) tuvo resultados mixtos en un estudio de seguimiento de 2 años de un…

Minimally invasive surfactant shows some benefit in infants’ first 2 years

Pediatric News , 13 Sep 2023

Minimally invasive surfactant therapy (MIST) had mixed results in a 2-year follow-up study of a randomized clinical trial of…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 2 additional news stories.